TROXIPIDE: A Novel Cytoprotective Agent in Acid Peptic Disorders
Abstract
No abstract
References
1. Katelaris P.H., Tippett G. H. K., Norbu P., Lowe D. G., Brennan R., and Farthing M. J. G., “Dyspepsia, Helicobacter pylori, and peptic ulcer in a randomly
selected population in India,” Gut. 1992;33(11): 1462– 1466.
2. Boparai V, Rajagopalan J, Triadafilopoulos G. Guide to the use of proton pump inhibitors in adult patients. Drugs. 2008;68(7):925-47.
3. Mine T, Kataoka A, Fujisaki J et al. Effects of cimetidine and troxipide on gastric mucosal prostaglandin synthesis in patients with chronic gastric ulcer. Curr Ther Res. 1991;50 (6): 878-87.
4. Kusugami K, Ina K, Hosokawa T, Kobayashi F, Kusajima H, et al. Troxipide, a novel antiulcer compound, has inhibitory effects on human neutrophil migration and activation induced by various stimulants. Dig Liver Dis. 2000; 32: 305-11.
5. Prescribing information, Aplace®, Kyorin Pharmaceutical Co.,Ltd, 2010.
6. Hyeoyun et al. Peptic ulcers for the clinical effectiveness of Troxipide. Latest Med. 1989; 32 (3): 125-31.
7. Momo K, Hoshina K, Ishibashi Y, Saito T, Preventive effects of troxipide on a newly developed model of acute gastric mucosal lesion (AGML) induced by
ischemia/reperfusion plus ammonia in the rat. Nippon Yakurigaku Zasshi, 1994. 104: 313-23.
8. Yanan Z, Furong Q, Weiijia W et al. Relative bioavailability and bioequivalance of troxipide capsules in healthy volunteers after a single oral administration.
Chinese J Clin Pharmacol. 2000; 19 (6).
9. Dewan B, Balasubramanian A. Troxipide in the management of gastritis: a randomized comparative trial in general practice. Gastroenterol Res Pract.
2010;758397. doi:10.1155/2010/758397
10. Dewan B. A parallel, randomized, comparative, double- blind, double-dummy clinical trial to evaluate the efficacy and safety of Troxipide versus Rabeprazole
in the Treatment of Gastritis & Gastric Ulcer. OJGas. 2013; doi:10.4236/ojgas.2013.
11. Dewan B, Shah D. An Open-Label, Multicenter Post Marketing Study to Assess the Symptomatic Efficacy and Safety of Troxipide [TroxipTM] in the Management of Acid Peptic Disorders in Indian Patients British Journal of Medicine & Medical Research, 2013. 3(4): 1881-1892.
selected population in India,” Gut. 1992;33(11): 1462– 1466.
2. Boparai V, Rajagopalan J, Triadafilopoulos G. Guide to the use of proton pump inhibitors in adult patients. Drugs. 2008;68(7):925-47.
3. Mine T, Kataoka A, Fujisaki J et al. Effects of cimetidine and troxipide on gastric mucosal prostaglandin synthesis in patients with chronic gastric ulcer. Curr Ther Res. 1991;50 (6): 878-87.
4. Kusugami K, Ina K, Hosokawa T, Kobayashi F, Kusajima H, et al. Troxipide, a novel antiulcer compound, has inhibitory effects on human neutrophil migration and activation induced by various stimulants. Dig Liver Dis. 2000; 32: 305-11.
5. Prescribing information, Aplace®, Kyorin Pharmaceutical Co.,Ltd, 2010.
6. Hyeoyun et al. Peptic ulcers for the clinical effectiveness of Troxipide. Latest Med. 1989; 32 (3): 125-31.
7. Momo K, Hoshina K, Ishibashi Y, Saito T, Preventive effects of troxipide on a newly developed model of acute gastric mucosal lesion (AGML) induced by
ischemia/reperfusion plus ammonia in the rat. Nippon Yakurigaku Zasshi, 1994. 104: 313-23.
8. Yanan Z, Furong Q, Weiijia W et al. Relative bioavailability and bioequivalance of troxipide capsules in healthy volunteers after a single oral administration.
Chinese J Clin Pharmacol. 2000; 19 (6).
9. Dewan B, Balasubramanian A. Troxipide in the management of gastritis: a randomized comparative trial in general practice. Gastroenterol Res Pract.
2010;758397. doi:10.1155/2010/758397
10. Dewan B. A parallel, randomized, comparative, double- blind, double-dummy clinical trial to evaluate the efficacy and safety of Troxipide versus Rabeprazole
in the Treatment of Gastritis & Gastric Ulcer. OJGas. 2013; doi:10.4236/ojgas.2013.
11. Dewan B, Shah D. An Open-Label, Multicenter Post Marketing Study to Assess the Symptomatic Efficacy and Safety of Troxipide [TroxipTM] in the Management of Acid Peptic Disorders in Indian Patients British Journal of Medicine & Medical Research, 2013. 3(4): 1881-1892.
Published
2019-09-13
How to Cite
Kavita Krishna, Panda B K. (2019). TROXIPIDE: A Novel Cytoprotective Agent in Acid Peptic Disorders. The Indian Practitioner, 67(6), 373-375. Retrieved from https://articles.theindianpractitioner.com/index.php/tip/article/view/799
Section
Review article
